QT prolongation and ventricular tachycardia due to roxithromycin;Roksitromisin kullanimina baǧli gelişen QT uzamazi ve ventriküler taşikardi

Anadolu Kardiyoloji Dergisi

Volumn 5, Issue 4, 2005, Pages 319-321

  Keskin, Serkan ^a   Sayah, Erhan ^a   Temeloǧlu, Ela ^a   Gürol, Tayfun ^a   Ekizoǧlu, Ismail ^a  

^a ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; HYDROXYZINE; LISINOPRIL; METOPROLOL; ROXITHROMYCIN; TRIMETAZIDINE;

ARTICLE; CARDIOVERSION; CASE REPORT; HEART VENTRICLE TACHYCARDIA; HUMAN; QT PROLONGATION; TORSADE DES POINTES;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; LONG QT SYNDROME; MIDDLE AGED; ROXITHROMYCIN; TACHYCARDIA, VENTRICULAR;

EID: 29544445639     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Gök H. Klinik Kardiyoloji. 2. baski. Konya: Nobel Tip Kitapevleri; 2002.
2. Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003; 21: 881-908.
3. Promphan W, Khongphatthanayothin A, Horchaiprasit K, Benjacholamas V. Roxithromycin induced torsade de pointes in a patient with complex congenital heart disease and complete atrioventricular block. Pacing Clin Electrophysiol 2003; 26: 1424-6.
4. Haffner S, Lapp H, Thurmann PA. Adverse drug reactions-case report. Dtsch Med Wochenschr 2002; 127: 1021.
5. Volberg WA, Koci BJ, Su W, Lin J, Zhou J. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320-7.
6. Woywodt A, Grommas U, Buth W, Rafflenbeul W. QT prolongation due to roxithromycin. Postgrad Med J 2000; 76: 651-3.
7. Akar N, Aydoǧdu S, Diker E. Ventriküler aritmilere genel yaklaşim. Anadolu Kardiyol Derg 2004; 3: 246-52.